Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fibrocartilaginous Embolism Presenting as Isolated L2-3 Radiculopathy without Spinal Cord Infarction.

American journal of physical medicine & rehabilitation·2026
Same author

Lymph-interpositional flap transfer promotes lymphatic flow restoration: A rabbit hindlimb model supports the lymph axiality concept.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2026
Same author

Coupling between environmental drivers and microbial networks in shaping marine plankton dynamics.

Marine environmental research·2025
Same author

Clinical Practice Guideline for Stroke Rehabilitation in Korea-Part 2: Rehabilitation for Motor and Sensory Function (2024).

Brain & NeuroRehabilitation·2025
Same author

Integrated diagnostic approaches for superficial radial neuropathy: The role of ultrasonography in enhancing morphological assessments.

PM & R : the journal of injury, function, and rehabilitation·2025
Same author

Free Jejunal Graft Vaginoplasty in Gender Affirmation Surgery: A Novel Technique.

Aesthetic plastic surgery·2025

Related Experiment Video

Updated: May 20, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Muscular polyarteritis nodosa.

Seung Nam Yang1, Nam Soon Cho, Hyun Soo Choi

  • 1Department of Physical Medicine and Rehabilitation, College of Medicine, Korea University, Ansan City, Korea.

Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|July 27, 2012
PubMed
Summary
This summary is machine-generated.

Polyarteritis nodosa (PAN) can manifest as severe calf pain. Early corticosteroid treatment is effective, but long-term management may require immunosuppressants for muscular PAN.

Related Experiment Videos

Last Updated: May 20, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Area of Science:

  • Rheumatology
  • Neurology
  • Vascular Medicine

Background:

  • Polyarteritis nodosa (PAN) is a systemic vasculitis that can affect various organs.
  • Muscular involvement in PAN, particularly presenting with calf pain, is uncommon.

Observation:

  • A 26-year-old male presented with severe calf pain and gait disturbance.
  • MRI revealed increased signal intensity in soleus and gastrocnemius muscles.
  • Soleus muscle biopsy confirmed acute necrotizing arteritis.

Findings:

  • High-dose oral corticosteroids provided rapid symptom relief for calf pain and ankle dorsiflexion.
  • Symptoms recurred upon corticosteroid dose tapering.
  • A combination of immunosuppressants achieved sustained symptomatic relief.

Implications:

  • Muscular PAN should be considered in the differential diagnosis of acute or subacute calf pain.
  • While initially responsive to corticosteroids, complete remission of muscular PAN may be challenging.
  • Long-term management may necessitate a multimodal approach including immunosuppressive therapy.